wbur.org
support wbur today!
Listen to this story
Manufacturing Depression?
photo

By guest host Jane Clayson:

Antidepressants are a multibillion dollar business in America and around the world. And therein, says psychotherapist Gary Greenberg, lies a big problem.

Pharmaceutical companies and researchers are casting their nets too wide to find new patients, calling normal, rational feelings a disease, says Greenberg. Some simple sadness, the occasional melancholy, is part of a normal life, he says, and getting rid of them may mean getting rid of the soul.

This hour On Point: manufacturing depression and the economy of melancholy.


Quotes from the Show:

“What really interested me about this experience [participating in a clinical trial study] was learning about the way that our experience of unhappiness or melancholy gets medicalized.”

“On the one hand there’re some real benefits to medicalizing suffering. … On the other hand, the cost of medicalizing depression, at least in my experience, was that the study was interested in everything except my experience.” Dr. Gary Greenburg

“The very reductionism that [Dr. Greenberg] disparages or at least critiques, is really necessary in order to make sense of the very complex data that every human brings into clinical work and clinical trials.” Dr. Jonathan Alpert

“The cost of not [medicalizing depression] is much higher.” Dr. Jonathan Alpert

“I am not against treating depression and unhappiness with drugs. … The sole question I am raising is whether their depression has to be medicalized in order to be treated.” Dr. Gary Greenburg

“Yes, I think it’s very important to distinguish illness from non-illness.” Peter Kramer

Guests:

Gary Greenberg, psychotherapist and uthor of an essay in the May issue of Harper’s Magazine called “Manufacturing Depression”;
Dr. Jonathan Alpert, Associate Director of the Depression Research Program at the Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School.;
Dr. Peter Kramer, a clinical professor of psychiatry and human behavior at Brown University and author of “Against Depression,” “Listening to Prozac” and “Freud: Inventor of the Modern Mind.”

 
 

Comments are closed.

Recent Shows
Poker: America’s Game
Thursday, November 19, 2009 image

Poker and American history. How the game of presidents, cowboys, gangsters, and online gamblers helped shape America.

Comments [10]
 
Google vs. Murdoch
Thursday, November 19, 2009 image

Rupert Murdoch wants to block the search giant from scooping free content from his newspapers. We’ll look at the staredown.

Comments [132]
On Point Blog
Michael Wolff and Jeff Jarvis on Murdoch v. Google

We had a rousing discussion about Google vs. Murdoch, and what it says about the whole future of news, with Michael Wolff, Jeff Jarvis, and Steven Brill. Here’s what Wolff and Jarvis had to say about the delusions of both Murdoch and Google.

More » | Comments [18]
 
Video: Google CEO Eric Schmidt

Last week, host Tom Ashbrook was on stage with Google CEO Eric Schmidt, asking him about some of the biggest technology and business issues of our time.
It was part of an MIT event held on Thursday, Nov. 5, to commemorate computer science professor Michael Hammer, who died last year. Here’s video of the full interview, courtesy of WBUR.org:

Among other things, Schmidt said the possibilities [...]

More » | Comments [4]
 
California, here we come! And we need your questions!

On Point is headed west!
No, no. Not for good. Only for one show. But it’s a very special show!  The NPR station in Thousand Oaks, California – KCLU – is celebrating their 15th anniversary. We’re lucky to have been on their airwaves for nearly seven years, and they invited us out west to host a live [...]

More » | Comments [10]